Composition:
FAROPT 300 mg ER Tablet contains Faropenem Sodium equivalent to Faropenem 300 mg in an extended-release formulation.
Description:
FAROPT 300 mg ER is a broad-spectrum antibiotic belonging to the penem class. It works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. The extended-release formulation helps maintain effective drug levels for a longer duration, improving therapeutic efficacy and compliance. It is commonly used in the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other susceptible bacterial infections.
Adverse Effects:
Common adverse effects may include nausea, vomiting, diarrhea, abdominal discomfort, headache, or skin rash. Less commonly, patients may experience allergic reactions, dizziness, or changes in liver enzyme levels. Severe hypersensitivity reactions are rare but possible.
Precautions:
This medicine should be used with caution in patients with a history of hypersensitivity to beta-lactam antibiotics such as penicillins or cephalosporins. Dose adjustment may be required in patients with renal impairment. Prolonged use may lead to superinfection with resistant organisms. Use during pregnancy and breastfeeding should be based on medical advice.
Storage:
Store FAROPT 300 mg ER Tablets in a cool and dry place, protected from moisture and direct sunlight. Keep out of reach of children. Use the medicine before the expiry date printed on the pack.
